Patient info Open main menu

Synjardy 5 mg/850 mg film-coated tablets – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
5 mg/850 mg
Contains active substances:

Patient leaflet - Synjardy 5 mg/850 mg film-coated tablets

1. What Synjardy is and what it is used for

What Synjardy is

Synjardy contains two active substances empagliflozi metformin. Each belongs to a group of medicines cal anti-diabetics”. These are medicines taken by mouth type 2 diabetes.

What is type 2 diabetes?

Type 2 diabetes is a disease that comes from both yo and your lifestyle. If you have type 2 diabetes, your p does not make enough insulin to control the level of in your blood, and your body is unable to use its own

n and

led “oral to treat

ur genes ancreas glucose insulin

effectively. This results in high levels of glucose in your blood which can lead to medical problems like heart disease, kidney disease, blindness, and poor circulation in your limbs.

How Synjardy works

Empagliflozin belongs to a group of medicines called sodium glucose co-transporter-2 (SGLT2) inhibitors. It works by blocking the SGLT2 protein in your kidneys. This causes blood sugar (glucose) to be removed in your urine. Metformin works in a different way to lower blood sugar levels, mainly by blocking glucose production in the liver.

Thereby Synjardy lowers the amount of su medicine can also help prevent heart disea

What Synjardy is used for

  • Synjardy is added to diet and exercise t

    diabetes in adult patients and children older whose diabetes cannot be contro metformin alone or metformin with oth

    gar in your blood. This se.

    o treat type 2

    aged 10 years and lled by adding

    er medicines for

    diabetes.

  • Synjardy can also be combined with ot

    treatment of diabetes. These may be m mouth or given by injection such as ins

  • In addition, Synjardy can be used as an

    both empagliflozin and metformin as si avoid overdose, do not continue taking metformin tablets separately, if you are

It is important that you continue with your plan as told by your doctor, pharmacist or

her medicines for the edicines taken by ulin.

alternative to taking ngle tablets. To

empagliflozin and taking this medicine.

diet and exercise nurse.

2. What you need to know before you take Synjardy

Do not take Synjardy

  • if you are allergic to empagliflozin, metformin or any of the

    other ingredients of this medicine (listed in section 6);

  • if you have uncontrolled diabetes, with, for example, severe

    hyperglycaemia (very high blood glucose), nausea, vomiting, diarrhoea, rapid weight loss, lactic acidosis (see ‘Risk of lactic acidosis’ below) or ketoacidosis. Ketoacidosis is a condition in which substances called ‘ketone bodies’

    accumulate in the blood and which can lead to diabetic pre-coma. Symptoms include stomach pain, fast and deep breathing, sleepiness or your breath developing an unusual fruity smell;

    • if you have had a diabetic pre-coma;
    • if you have serious kidney problems. Your doctor may limit

      your daily dose or ask you to take a different medicine (see also section 3, ‘How to take Synjardy’).

    • if you have a severe infection such as an infection affecting

      your lung or bronchial system or your kidney. Severe infections may lead to kidney problems, which can put you at risk for lactic acidosis (see ‘Warnings and precautions’);

    • if you have lost a lot of water

      e.g. due to long-lasting or sev vomited several times in a ro kidney problems, which can (see ‘Warnings and precautio

    • if you are treated for acute h

      a heart attack, have severe p (such as shock) or have breat to a lack in oxygen supply to for lactic acidosis (see sectio

    • if you have problems with yo
    • if you drink large amounts of

      only from time to time (see s

      from your body (dehydration), ere diarrhoea, or if you have w. Dehydration may lead to put you at risk for lactic acidosis ns’);

      eart failure or have recently had roblems with your circulation hing difficulties. This may lead tissue which can put you at risk n ‘Warnings and precautions’); ur liver;

      alcohol, either every day or ection “Synjardy with alcohol”).

Warnings and precautions

Risk of lactic acidosis

Synjardy may cause a very rare, called lactic acidosis, particularl properly. The risk of developing with uncontrolled diabetes, serio or alcohol intake, dehydration (s liver problems and any medical the body has a reduced supply o heart diseases).

If any of the above apply to you, instructions.

but very serious side effect y if your kidneys are not working lactic acidosis is also increased us infections, prolonged fasting ee further information below), conditions in which a part of f oxygen (such as acute severe

talk to your doctor for further

Stop taking Synjardy for a short that may be associated with deh

body fluids) such as severe vomi to heat or if you drink less fluid t for further instructions.

Stop taking Synjardy and contac hospital immediately if you exp of lactic acidosis, as this conditi Symptoms of lactic acidosis incl

  • vomiting
  • stomach ache (abdominal pa
  • muscle cramps
  • a general feeling of not being

    time if you have a condition ydration (significant loss of ting, diarrhoea, fever, exposure han normal. Talk to your doctor

    t a doctor or the nearest erience some of the symptoms

    on may lead to coma.

    ude:

    in)

    well with severe tiredness

  • difficulty in breathing
  • reduced body temperature and heartbeat

Talk to your doctor promptly for further instructions

  • if you are known to suffer from a genetically inherited

    disease affecting mitochondria (the energy-producing components within cells) such as MELAS syndrome (Mitochondrial Encephalopathy, myopathy, Lactic acidosis and Stroke-like episodes) or Maternal inherited diabetes and deafness (MIDD).

    • if you have any of these symptoms after starting metformin:

      seizure, declined cognitive abilities, difficulty with body movements, symptoms indicating nerve damage (e.g. pain or numbness), migraine and deafness.

Lactic acidosis is a medical emergency and must be treated in a hospital.

Talk to your doctor, pharmacist or nurse before taking this medicine, and during treatment:

  • if you experience rapid weight loss, feeling sick or being

    sick, stomach pain, excessive thirst, fast and deep breathing,

    confusion, unusua to your breath, a s a different odour t or the nearest hos medicine until furt symptoms could b but serious, somet with diabetes beca in your urine or blo diabetic ketoacido fasting, excessive reductions in insul major surgery or s

  • if you have “type 1

    l sleepiness or tiredness, a sweet smell weet or metallic taste in your mouth, or

    o your urine or sweat, contact a doctor pital straight away and stop taking this her advice from your doctor. These e a sign of “diabetic ketoacidosis” – a rare, imes life-threatening problem you can get use of increased levels of “ketone bodies” od, seen in tests. The risk of developing sis may be increased with prolonged alcohol consumption, dehydration, sudden in dose, or a higher need of insulin due to erious illness;

    diabetes” – this type usually starts when

    you are young and You should not tak

  • might be at risk of

    o if you are being

    not able to eat

    o if you are takin

    [diuretics] or lo

    o if you are 75 ye Possible signs are l

    Your doctor may a recover to prevent ways to prevent de

  • if you have a serio

    tract with fever. Yo

    your body does not produce any insulin. e Synjardy if you have type 1 diabetes; dehydration, for example:

    sick, have diarrhoea or fever, or if you are or drink

    g medicines that increase urine production wer blood pressure

    ars old or older.

    isted in section 4 under ‘dehydration’. sk you to stop taking Synjardy until you loss of too much body fluid. Ask about hydration.

    us infection of the kidney or the urinary ur doctor may ask you to stop taking

    Synjardy until you

  • if you need to und

    contrast agents (su given below in “Ot

Talk to your doctor im of symptoms of pain, genitals or the area be fever or feeling genera a sign of a rare but se called necrotising fasc gangrene which destr gangrene has to be tre

have recovered;

ergo an examination with iodination ch as X-ray or scan). More information is her medicines and Synjardy”.

mediately if you develop a combination tenderness, redness, or swelling of the tween the genitals and the anus with lly unwell. These symptoms could be rious or even life-threatening infection, iitis of the perineum or Fournier’s oys the tissue under the skin. Fournier’s ated immediately.

Surgery

If you need to have major surgery you must stop taking Synjardy during and for some time after the procedure. Your doctor will decide when you must stop and when to restart your treatment with Synjardy.

Kidney function

During treatment with Synjardy, your doctor will check your kidney function at least once a year or more frequently if you are elderly and/or if you have worsening kidney function.

Foot care

Like for all diabetic patients it is important to check your feet regularly and adhere to any other advice regarding foot care given by your health care professional.

Urine glucose

Because of how this medicine works, your urine will test positive for sugar while you are taking this medicine.

Children and adolescents

Synjardy can be used in children aged 10 years and older for the treatment of type 2 diabetes mellitus.

Due to limit

ed data caution is recommended when used in children ag

ed between 10 and 12 years.

No data are

available in children below 10 years of age.

Other medi

cines and Synjardy

If you need

to have an injection of a contrast medium that contains io

dine into your bloodstream, for example in the context of a

n X-ray or scan, you must stop taking Synjardy before or at

the time of the injection. Your doctor will decide when you m

ust stop and when to restart your treatment with

Synjardy.

Tell your do

ctor if you are taking, have recently taken or might take any ot

her medicines. You may need more frequent blood glucose and

kidney function tests, or your doctor may need to adjust th

e dosage of Synjardy. It is especially important to mention th

e following:

  • medicin

    es which increase urine production (diuretics), as

    Synjardy

    may increase the risk of losing too much fluid. Your doctor

    may ask you to stop taking Synjardy. Possible signs of losing to

    o much fluid from your body are listed in section 4.

  • other m

    edicines that lower the amount of sugar in your blood su

    ch as insulin or a “sulphonylurea” medicine. Your doctor

    may want to lower the dose of these other medicines, to preve

    nt your blood sugar levels from getting too low

    (hypogly

    caemia).

  • medicin

    es that may change the amount of metformin in your blood, e

    specially if you have reduced kidney function (such as verapam

    il, rifampicin, cimetidine, dolutegravir, ranolazine, trimetho

    prim, vandetanib, isavuconazole, crizotinib, olaparib

    ).

  • broncho

    dilators (beta-2 agonists) which are used to treat asthma.

  • corticos

    teroids (given by mouth, as an injection, or inhaled), which ar

    e used to treat inflammation in diseases like asthma and arth

    ritis.

  • medicin

    es used to treat pain and inflammation (NSAID and

    COX-2-i

    nhibitors, such as ibuprofen and celecoxib).

  • certain

    medicines for the treatment of high blood pressure

    (ACE inh

    ibitors and angiotensin II receptor antagonists).

  • medicin

    es that contain alcohol (see section ‘Synjardy with alcohol’

    ).

  • iodinated contrast agents (medicines used during an X-ray, see section ‘Warnings and precautions’).
  • if you are taking lithium because Synjardy can lower the amount of lithium in your blood.

Synjardy with alcohol

Avoid excessive alcohol intake while taking Synjardy since this may increase the risk of lactic acidosis (see section ‘Warnings and precautions’).

Synjardy® 5 mg/850 mg film-coated tablets Synjardy® 5 mg/1 000 mg film-coated tablets Synjardy® 12.5 mg/850 mg film-coated tablets Synjardy® 12.5 mg/1 000 mg film-coated tablets

empagliflozin/metformin hydrochloride

Package leaflet: Information for the patient

Synjardy® 5 mg/850 mg

film-coated tablets Synjardy® 5 mg/1 000 m

g

film-coated tablets Synjardy

®

12.5 mg/850

mg

film-coated tablets Synjardy® 12.5 mg/1 00 film-coated tablets

empagliflozin/metformin hydrochl

Read all of this leaflet carefully before you start takin

  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor,

    0 mg

    oride

    g this medicine because it contains important informatio

    pharmacist or nurse.

    n for you.

  • This medicine has been prescribed for you only. D

    the same as yours.

  • If you get any side effects, talk to your doctor, pha

    leaflet. See section 4.

    o not pass it on to others. It may harm them, even if thei

    rmacist or nurse. This includes any possible side effects

    r signs of illness are

    not listed in this

    abcd

Synjardy® 5 mg/850 mg

film-coated tablets

Synjardy® 5 mg/1 000 mg

film-coated tablets

Synjardy® 12.5 mg/850 mg

film-coated tablets

Synjardy® 12.5 mg/1 000 mg film-coated tablets

empagliflozin/metformin hydrochloride

abcd

abcd Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Do not take Synjardy if you are pregnant. It is unknown if this medicine is harmful to the unborn child.

Metformin passes into human milk in small amounts. It is not known whether empagliflozin passes into human breast milk. Do not take Synjardy if you are breast-feeding.

Driving and using machines

Synjardy has minor influence on the ability to drive a

nd use

machines.

Taking this medicine in combination with medicines

called

sulphonylureas or with insulin can cause blood sugar

levels to

drop too low (hypoglycaemia), which may cause sym

ptoms such

as shaking, sweating and change in vision, and may a

ffect your

ability to drive and use machines. Do not drive or use

any tools

or machines if you feel dizzy while taking Synjardy.

3. How to take Synjardy

Always take this medicine exactly as your doctor has tol

d you.

Check with your doctor or pharmacist if you are not sur

e.

How much to take

The dose of Synjardy varies depending on your condi

tion and

the doses of diabetes medicines you currently take. Y

our doctor

will adjust your dose as necessary and tell you exactl

y which

strength of the medicine to take.

The recommended dose is one tablet twice a day. You

r doctor

will normally start Synjardy treatment by prescribing t

he

strength of tablet that supplies the same dose of metf

ormin

you are already taking (850 mg or 1 000 mg twice a d

ay), and

the lowest dose of empagliflozin (5 mg twice a day). If

you

are already taking both medicines separately, your do

ctor will

start treatment with tablets of Synjardy that will supp

ly the

same amount of both. If you have reduced kidney fun

ction,

your doctor may prescribe a lower dose or decide to u

se an

alternative medicine.

Taking this medicine

  • Swallow the tablet whole with water.
  • Take the tablets with meals to lower your chance

    of an upset

    stomach.

  • Take the tablet twice daily by mouth.

Your doctor may prescribe Synjardy together with an

other

diabetes medicine. Remember to take all medicines a

s directed

by your doctor to achieve the best results for your he

alth. Your

doctor may need to adjust your doses to control your blood sugar.

Appropriate diet and exercise help your body use its blood sugar better. It is important to stay on the diet and exercise program recommended by your doctor while taking Synjardy.

If you take more Synjardy than you should

If you take more Synjardy tablets than you should have, you may experience lactic acidosis. Symptoms of lactic acidosis are non-specific such as feeling or being very sick, vomiting,

stomach ache with muscle cramps, a general feeling of not being well with severe tiredness, and difficulty in breathing. Further symptoms are reduced body temperature and heartbeat. If this happens to you, you may need immediate hospital treatment, as lactic acidosis can lead to coma. Stop taking this medicine immediately and contact a doctor or the nearest hospital straight away (see section 2). Take the medicine pack with you.

If you forget to take Synjardy

If you miss a dose, take it as soon as you remember. If you do not remember until it is time for your next dose, skip the missed dose and go back to your regular schedule. Do not take a double

dose of this medicine.

If you stop taking Synjardy

Do not stop taking Synjardy without first c doctor, unless you suspect you have diabet acidosis, or if you have a condition that m dehydration (see section 2 “warnings and blood sugar levels may increase when you

If you have any further questions on the us ask your doctor, pharmacist or nurse.

4. Possible side effects

onsulting your

ic ketoacidosis, lactic ay be associated with precautions”). Your stop taking Synjardy.

e of this medicine,

Like all medicines, this medicine can cause although not everybody gets them.

Contact a doctor or the nearest hospital st have any of the following side effects:

Severe allergic reaction, seen with uncom (may affect up to 1 in 100 people)

Possible signs of severe allergic reaction m

  • swelling of the face, lips, mouth, tongu

    lead to difficulty breathing or swallowin

Lactic acidosis, seen very rarely (may affec 10 000 people)

side effects,

raight away if you

mon frequency

ay include:

e, or throat that may g

t up to 1 in

Synjardy may cause a very rare but very se called lactic acidosis (see section 2). If this stop taking Synjardy and contact a doctor hospital immediately, as lactic acidosis ma

Diabetic ketoacidosis, seen rarely (may aff 1 000 people)

These are the signs of diabetic ketoacidosi

  • increased levels of “ketone bodies” in y
  • rapid weight loss
  • feeling sick or being sick
  • stomach pain
  • excessive thirst
  • fast and deep breathing

    rious side effect happens you must or the nearest

    y lead to coma.

    ect up to 1 in

    s (see section 2): our urine or blood

  • confusion
  • unusual sleepiness or tiredness
  • a sweet smell to your breath, a sweet or metallic taste

    in your mouth or a different odour to your urine or sweat.

This may occur regardless of blood glucose level. Your doctor may decide to temporarily or permanently stop your treatment with Synjardy.

Contact your doctor as soon as possible if you notice the following side effects:

Low blood sugar (hypoglycaemia), seen very commonly (may affect more than 1 in 10 people)

If you take Synjardy with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin, your risk of getting low blood sugar is increased. The signs of low blood sugar may include:

  • shaking, sweating, feeling very anxious or confused, fast

    heart beat

  • excessive hunger, headache

Your doctor will tell you how to t and what to do if you get any of symptoms of low blood sugar, e snack or drink fruit juice. Measu and rest.

Urinary tract infection, seen co 10 people)

The signs of urinary tract infecti

  • burning sensation when pass
  • urine that appears cloudy
  • pain in the pelvis, or mid-bac

    infected)

    reat low blood sugar levels the signs above. If you have at glucose tablets, a high sugar re your blood sugar if possible

    mmonly (may affect up to 1 in

    on are:

    ing urine

    k pain (when kidneys are

An urge to pass urine or more fr the way Synjardy works, but the tract infection. If you note an inc should also contact your doctor.

Dehydration, seen uncommonly 100 people)

The signs of dehydration are not

  • unusual thirst
  • lightheadedness or dizziness
  • fainting or loss of consciousn

Other side effects while taking

equent urination may be due to y can also be signs of urinary rease in such symptoms, you

(may affect up to 1 in

specific, but may include:

upon standing

ess

Synjardy:

Very common

  • feeling sick (nausea), vomitin
  • diarrhoea or stomach ache
  • loss of appetite

Common

  • genital yeast infection (thrus
  • passing more urine than usu

    often

  • itching
  • rash or red skin – this may b

    bumps, oozing fluid or bliste

  • changes to the way things ta
  • thirst

    g

    h)

    al or needing to pass urine more

    e itchy and include raised rs

    ste

  • blood tests may show an increase in blood fat (cholesterol)

    levels in your blood

  • constipation
  • decreased or low vitamin B12 levels in the blood (symptoms

    may include extreme tiredness (fatigue), a sore and red tongue (glossitis), pins and needles (paraesthesia) or pale or yellow skin). Your doctor may arrange some tests to find out the cause of your symptoms because some of these may also be caused by diabetes or due to other unrelated health problems.

    Uncommon

    • hives
    • straining or pain when emptying the bladder
    • blood tests may show a decrease in kidney function

      (creatinine or urea)

    • blood tests may show increases in the amount of red blood cells in your blood (haematocrit)

Rare

  • necrotising fasciitis of the perineum or Fournier’s gangrene, a serious soft tissue infection of the genitals or the area between the genitals and the anus

Very rare

  • abnormalities in liv

    liver (hepatitis)

  • redness of the skin
  • inflammation of th

Reporting of side effe

If you get any side eff nurse. This includes a leaflet. You can also r below). By reporting s information on the sa

er function tests, inflammation of the

(erythema)

e kidneys (tubulointerstitial nephritis)

cts ects, talk to your doctor, pharmacist or ny possible side effects not listed in this eport side effects directly (see details ide effects you can help provide more fety of this medicine.

Yellow Card Scheme Website: www.mhra.g Yellow Card in the Go

5. How to store Sy

Keep this medicine ou

Do not use this medic on the blister and the to the last day of that

This medicine does n

ov.uk/yellowcard or search for MHRA ogle Play or Apple App Store njardy t of the sight and reach of children.

ine after the expiry date which is stated carton after ‘EXP’. The expiry date refers month.

ot require any special storage conditions.

Do not use this medic damaged or shows sig

Do not throw away an waste. Ask your pharm you no longer use. Th environment.

6. Contents of the

What Synjardy contai

The active substances Each Synjardy 5 mg/8

ine if you notice that the packaging is ns of tampering.

y medicines via wastewater or household acist how to throw away medicines ese measures will help protect the pack and other information ns are empagliflozin and metformin. 50 mg film-coated tablet (tablet) contains

5 mg empagliflozin and 850 mg metformin hydrochloride. Each Synjardy 5 mg/1 000 mg film-coated tablet (tablet) contains 5 mg empagliflozin and 1 000 mg metformin hydrochloride.

Each Synjardy 12.5 mg/850 mg film-coated tablet (tablet) contains 12.5 mg empagliflozin and 850 mg metformin hydrochloride.

Each Synjardy 12.5 mg/1 000 mg film-coated tablet (tablet) contains 12.5 mg empagliflozin and 1 000 mg metformin hydrochloride.

The other ingredient(s) are:

  • Tablet core: maize starch, copovidone, colloidal anhydrous silica, magnesium stearate.
  • Film coating: hypromellose, macrogol 400, titanium dioxide

    (E171), talc.

    Synjardy 5 mg/850 mg and Synjardy 5 mg/1 000 mg tablets also contain iron oxide yellow (E172). Synjardy 12.5 mg/850 mg and Synjardy 12.5 mg/1 000 mg tablets also contain iron oxide black (E172) and iron oxide red (E172).

What Synjardy looks like and contents of the pack

Synjardy 5 mg/850 mg film-coated tablets are yellowish white, oval, biconv logo on one long and ha Synjardy 5 yellow, oval Ingelheim l is 21.1 mm Synjardy 12 oval, biconv logo on one long and ha Synjardy 12 brownish p Boehringer

ex. They have “S5” and the Boehringer Ingelheim side and “850” on the other. The tablet is 19.2 mm s a width of 9.4 mm.

mg/1 000 mg film-coated tablets are brownish , biconvex. They have “S5” and the Boehringer ogo on one side and “1000” on the other. The tablet long and has a width of 9.7 mm.

.5 mg/850 mg film-coated tablets are pinkish white, ex. They have “S12” and the Boehringer Ingelheim side and “850” on the other. The tablet is 19.2 mm s a width of 9.4 mm.

.5 mg/1 000 mg film-coated tablets are dark urple, oval, biconvex. They have “S12” and the Ingelheim logo on one side and “1000” on the other.

The tablet i

The tablets unit dose bl 56 × 1, 60 × multipacks 90 × 1) and

Not all pack

Marketing

Boehringer Binger Stras 55216 Ingel

s 21.1 mm long and has a width of 9.7 mm.

are available in PVC/PVDC/aluminium perforated isters. The pack sizes are 10 × 1, 14 × 1, 30 × 1, 1, 90 × 1 and 100 × 1 film-coated tablets and containing 120 (2 packs of 60 × 1), 180 (2 packs of 200 (2 packs of 100 × 1) film-coated tablets.

sizes may be marketed.

Authorisation Holder

Ingelheim International GmbH se 173 heim am Rhein

Germany

Manufactur

Dragenoph Göllstraße 84529 Tittm Germany

For any info local repres

United King

Boehringer Tel: +44 134

er arm Apotheker Püschl GmbH

1 oning rmation about this medicine, please contact the entative of the Marketing Authorisation Holder:

dom

Ingelheim Ltd.

4 424 600

This leaflet was last revised in 07/2026.

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PLGB 14598/0224

Last revision stated in the text: July 2026 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Synjardy 5 mg/850 mg film-coated tablets

Prescription needed? Yes, prescription-only medicine (POM)
Active substances Metformin, Empagliflozin
Strength 5 mg/850 mg
Pharmaceutical form Oral tablet
How is it taken Oral
Pack sizes 56 tablet
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Drug group (ATC)
  1. A Alimentary tract and metabolism drugs
    1. A10 Drugs used in diabetes
      1. A10B Blood glucose lowering drugs, excl. insulins
        1. A10BD Combinations of oral blood glucose lowering drugs
          1. A10BD20 metformin and empagliflozin
Marketing authorisation PLGB 14598/0224
Codes GTIN 5012816099777 · BNF 06010203

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.